Correcting and replacing GRAIL announces positive validation data for its multi-cancer early detection test
Ninth paragraph, first sentence of the release should read: In the group of more than 20 cancer types,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Oct 19
Ninth paragraph, first sentence of the release should read: In the group of more than 20 cancer types,…
09 Oct 19
The agreement grants QIAGEN non-exclusive rights to develop and globally commercialize IVD kits to be used together with…
04 Oct 19
Dante Labs to use Illumina Technology to offer consumer access to whole genome sequencing for disease and health…
04 Oct 19
The REMEDIAL III Clinical study demonstrated that RenalGuard Therapy is more effective in preventing the composite of CI-AKI…
01 Oct 19
Inscripta introduced benchtop platform for digital genome engineering, featuring software, consumables, an instrument, and assays for precisely engineering…
01 Oct 19
The PROMISE Clinical Study has been designed to evaluate the safety and efficacy of the Eversense CGM System…
25 Sep 19
The target yield increase is accomplished by combining the ability to process a wide range of sample volumes…
25 Sep 19
Approval of AmpiProbe HBV viral load assay represents milestone in providing comprehensive menu of molecular diagnostic tests for…
23 Sep 19
The device would allow the user to identify WMD exposure through epigenetic signatures even in the absence of…
23 Sep 19
The cobas Babesia test can detect the four common species of Babesia and is Roche’s first commercially available…